8-K
Current Report
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-069785
Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading axsm-20250508.htm…